Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
OpenAI and Clearlake Capital Partner to Accelerate AI Adoption Across Clearlake’s Portfolio
-
Bioxytran Leverages Artificial Super Intelligence (ASI) to Design Broad-Spectrum Antiviral and Anti-Cancer Metastasis Drugs
-
TOP Financial Group Limited Announces Strategic Expansion to Launch Artificial Intelligence Division and Integrate Advanced AI Across Core Brokerage and FinTech Operations
-
LGI Homes, Inc. Reports Strong Second Quarter 2026 Results and Increases Full-Year 2026 Average Sales Price and Homebuilding Gross Margin Guidance Ranges
-
Strata Critical Medical Announces Second Quarter 2026 Results
-
BellRing Brands Reports Results for the Third Quarter of Fiscal Year 2026; Updates Fiscal Year 2026 Outlook
-
Certara Reports Second Quarter 2026 Financial Results
-
Odyssey Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
-
Arvinas Reports Second Quarter 2026 Financial Results and Provides Corporate Update
-
Aeluma Names Jason Taylor Senior Director of Program and Project Management
-
TRISO-X Announces 70-Acre Expansion of Oak Ridge Nuclear Fuel Campus
-
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director
-
Lisata Therapeutics Provides Update Following Termination of Merger Agreement
-
Cloud Range Advances How Organizations Measure and Demonstrate Cyber Readiness with New Performance Portal™ Enhancements
-
Shoals Technologies Group, Inc. Reports Financial Results for Second Quarter 2026
-
iBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer
-
CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement
-
RYTHM, Inc. Reports Second Quarter 2026 Results
-
Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
Beam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-302 Trial in Alpha-1 Antitrypsin Deficiency (AATD)
-
Descartes Sets Date to Announce Second Quarter Fiscal 2027 Financial Results
-
Oblenio Announces First Patients Dosed in Innovative Phase 1a Trial of LBL-051 in Refractory Autoimmune Diseases
-
ZEO ScientifiX Launches First-of-Its-Kind ZEO Xperience, a Three-Day Immersive Regenerative Medicine Experience for Healthcare Professionals
-
European Building Materials Celebrates Two RIBA Regional Award Wins for 2026
-
Viatris Announces Quarterly Dividend
-
AMETEK Announces Record Second Quarter 2026 Results and Raises Full Year Guidance
-
Wheels Up Announces Second Quarter Results
-
USA Compression Partners Reports Second-Quarter 2026 Results
-
Ryder CEO John Diez to Address Deutsche Bank’s Chicago Industrials Summit
-
Surf Air Mobility Publishes Updated Investor Presentation
-
YieldMax® ETFs Announces Distributions on BIGY, RNTY and SOXY
-
YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
-
Rhythm Pharmaceuticals Announces Preliminary Data from Phase 2 Trial that Showed RM-718 Demonstrated Positive Efficacy Signal in Acquired Hypothalamic Obesity
-
Behind Every Breath Is a Story: World NTM Day 2026 Spotlights the Patients Behind an Underrecognized Lung Disease
-
The Middle Class Is Out of Reach: Workers Fall $52,000 Short in Every Major U.S. Metro
-
Timken Reports Second-Quarter 2026 Results
-
Energizer Holdings, Inc. Announces Fiscal 2026 Third Quarter Results
-
Kimco Realty® Announces Second Quarter 2026 Results
-
ScottsMiracle-Gro Announces Financial Targets and Capital Allocation Strategy During Investor Day 2026 at NYSE
-
Senmiao Technology Limited Engages Strategic Advisory Firm to Support Government Relations and Strategic Advisory Efforts
-
Options Announces the Availability of Kimi K3 on Its PrivateMind Platform At No Additional Cost to Existing Customers
-
MPLX LP Reports Second-Quarter 2026 Financial Results
-
Aptiv Reports Second Quarter 2026 Financial Results
-
SOPHiA GENETICS Reports Second Quarter 2026 Results
-
Marathon Petroleum Corp. Reports Second-Quarter 2026 Results
-
Versigent Reports Second Quarter 2026 Results
-
Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance
-
Havertys Furniture Reports Operating Results for Second Quarter 2026
-
HawkEye 360 Schedules Conference Call to Discuss Second Quarter 2026 Financial Results
-
Descartes Introduces New AI-Powered Free Trade Intelligence (FTI) Solution to Help Reduce Trade Costs
